Market Share of Pancreatic Cancer Therapeutics And Diagnostics Industry
The pancreatic cancer therapeutics and diagnostics market is highly competitive, with many key players dominating the market. The presence of major market players like Novartis AG, Pfizer Inc., Immunovia AB, AstraZeneca PLC, Myriad Genetics Inc., and Viatris Inc. is intensifying the competition. The market players are adopting strategies, such as rising R&D investments, mergers, acquisitions, and product innovations, to sustain the increasing market rivalry.
Pancreatic Cancer Therapeutics and Diagnostics Market Leaders
-
Myriad Genetics, Inc.
-
Pfizer, Inc
-
Novartis AG
-
AstraZeneca plc
-
Immunovia AB
*Disclaimer: Major Players sorted in no particular order
